← Browse by Condition
Medical Condition
epithelial tumors malignant
Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1
NCT05141474 EARLY_Phase 1
Recruiting
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors
Enrollment
10 pts
Location
Spain
Sponsor
Vall d'Hebron Institute of Onc...
NCT07400263
Recruiting
Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors
Enrollment
30 pts
Location
China
Sponsor
Peking University People's Hos...